Literature DB >> 28124442

Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.

Sarah R Hoffman1, Tam Le2, Alexandre Lockhart1, Ayodeji Sanusi3, Leila Dal Santo3, Meagan Davis4, Dana A McKinney5, Meagan Brown4, Charles Poole1, Corinne Willame6, Jennifer S Smith1,7.   

Abstract

A systematic review of the literature was conducted to determine the estimates of and definitions for human papillomavirus (HPV) persistence in women following treatment of cervical intra-epithelial neoplasia (CIN). A total of 45 studies presented data on post-treatment HPV persistence among 6,106 women. Most studies assessed HPV persistence after loop excision (42%), followed by conization (7%), cryotherapy (11%), laser treatment (4%), interferon-alpha, therapeutic vaccination, and photodynamic therapy (2% each) and mixed treatment (38%). Baseline HPV testing was conducted before or at treatment for most studies (96%). Follow-up HPV testing ranged from 1.5 to 80 months after baseline. Median HPV persistence tended to decrease with increasing follow-up time, declining from 27% at 3 months after treatment to 21% at 6 months, 15% at 12 months, and 10% at 24 months. Post-treatment HPV persistence estimates varied widely and were influenced by patient age, HPV-type, detection method, treatment method, and minimum HPV post-treatment testing interval. Loop excision and conization appeared to outperform cryotherapy procedures in terms of their ability to clear HPV infection. This systematic review provides evidence for the substantial heterogeneity in post-treatment HPV DNA testing practices and persistence estimates.
© 2017 UICC.

Entities:  

Keywords:  CIN; HPV; HPV persistence; cervical cancer; human papillomavirus

Mesh:

Year:  2017        PMID: 28124442      PMCID: PMC5606195          DOI: 10.1002/ijc.30623

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  59 in total

1.  Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.

Authors:  Ali Baloglu; Dilek Uysal; Incim Bezircioglu; Merve Bicer; Ayşegul Inci
Journal:  Arch Gynecol Obstet       Date:  2009-11-26       Impact factor: 2.344

Review 2.  Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.

Authors:  Esther van der Heijden; Alberto D Lopes; Andrew Bryant; Ruud Bekkers; Khadra Galaal
Journal:  Cochrane Database Syst Rev       Date:  2015-01-06

3.  Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies.

Authors:  R Tachezy; I Mikysková; V Ludvíková; L Rob; T Kucera; V Slavík; A Beková; H Robová; M Pluta; E Hamsíková
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

Review 4.  The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.

Authors:  Anne F Rositch; Heidi M Soeters; Tabatha N Offutt-Powell; Bradford S Wheeler; Sylvia M Taylor; Jennifer S Smith
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

5.  Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ).

Authors:  Luís Otávio Zanatta Sarian; Sophie Françoise Mauricette Derchain; Denise da Rocha Pitta; Sirlei Siani Morais; Silvia Helena Rabelo-Santos
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

6.  Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.

Authors:  Julie Heymans; Ina H Benoy; Willy Poppe; Christophe E Depuydt
Journal:  Int J Cancer       Date:  2011-02-11       Impact factor: 7.396

Review 7.  Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.

Authors:  Jill Koshiol; Lisa Lindsay; Jeanne M Pimenta; Charles Poole; David Jenkins; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2008-05-15       Impact factor: 4.897

8.  Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade III - A prospective study.

Authors:  Nobutaka Nagai; Keiji Mukai; Takafumi Oshita; Yuko Shiroyama; Koso Ohama
Journal:  Int J Mol Med       Date:  2004-04       Impact factor: 4.101

9.  Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia.

Authors:  A Aerssens; P Claeys; E Beerens; A Garcia; S Weyers; L Van Renterghem; M Praet; M Temmerman; R Velasquez; C A Cuvelier
Journal:  Cytopathology       Date:  2008-05-28       Impact factor: 2.073

Review 10.  HPV testing in the context of post-treatment follow up (test of cure).

Authors:  Kate Cuschieri; Ramya Bhatia; Margaret Cruickshank; Peter Hillemanns; Marc Arbyn
Journal:  J Clin Virol       Date:  2015-10-22       Impact factor: 3.168

View more
  20 in total

1.  Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women.

Authors:  Xiaomeng Ma; Katherine Harripersaud; Kumi Smith; Christopher K Fairley; Huachun Zou; Zhuoru Zou; Yueyun Wang; Guihua Zhuang; Lei Zhang
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

2.  Association between human papillomavirus and chlamydia trachomatis infection risk in women: a systematic review and meta-analysis.

Authors:  Giulia Naldini; Chiara Grisci; Manuela Chiavarini; Roberto Fabiani
Journal:  Int J Public Health       Date:  2019-06-08       Impact factor: 3.380

3.  HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions.

Authors:  Carla Henere; Aureli Torné; Anna Llupià; Marta Aldea; Cristina Martí; Ariel Glickman; Adela Saco; Lorena Marimon; Carolina Manzotti; Natalia Rakislova; Jaume Ordi; Marta Del Pino
Journal:  Vaccines (Basel)       Date:  2022-06-01

Review 4.  Current Status of Human Papillomavirus Infection and Cervical Cancer in the Philippines.

Authors:  Ryan C V Lintao; Leslie Faye T Cando; Glenmarie Angelica S Perias; Ourlad Alzeus G Tantengco; Ian Kim B Tabios; Clarissa L Velayo; Sheriah Laine M de Paz-Silava
Journal:  Front Med (Lausanne)       Date:  2022-06-20

5.  Molecular progression to cervical precancer, epigenetic switch or sequential model?

Authors:  Belinda Nedjai; Caroline Reuter; Amar Ahmad; Rawinder Banwait; Rhian Warman; James Carton; Sabrina Boer; Jack Cuzick; Attila T Lorincz
Journal:  Int J Cancer       Date:  2018-07-03       Impact factor: 7.396

6.  Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang.

Authors:  Sulaiya Husaiyin; Lili Han; Lin Wang; Chunhua Ma; Zumurelaiti Ainiwaer; Nuermanguli Rouzi; Mireguli Akemujiang; Hatiguli Simayil; Zumulaiti Aniwa; Rouzi Nurimanguli; Mayinuer Niyazi
Journal:  BMC Cancer       Date:  2018-11-23       Impact factor: 4.430

7.  Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis.

Authors:  Mei Luo; JiaJie Yu; ShuYi Zhu; Li Huang; Yu Chen; ShaoBin Wei
Journal:  PLoS One       Date:  2019-03-01       Impact factor: 3.240

Review 8.  The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.

Authors:  Anna Rosa Garbuglia; Daniele Lapa; Catia Sias; Maria Rosaria Capobianchi; Paola Del Porto
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

9.  Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia.

Authors:  Ellinor Östensson; Karen Belkić; Torbjörn Ramqvist; Miriam Mints; Sonia Andersson
Journal:  Oncol Lett       Date:  2021-01-31       Impact factor: 2.967

10.  Clearance and persistence of the human papillomavirus infection among Cameroonian women.

Authors:  Mohamed Akaaboune; Bruno Kenfack; Manuela Viviano; Liliane Temogne; Rosa Catarino; Eveline Tincho; Joel Mbobda; Phuong Lien Tran; Roxane Camail; Pierre Vassilakos; Patrick Petignat
Journal:  Womens Health (Lond)       Date:  2018 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.